The Chile Cardiovascular Devices Market is expected to register a CAGR of 2.4% during the forecast period. The major factors driving the growth of the market in Chile are due to technological advancements, increasing cases of cardiovascular diseases, and increased adoption of minimally invasive procedures.
Cardiovascular disease is a major health problem in Chile. In Chile, the HEARTS program, a tool that provides a strategic approach to improving cardiovascular health through primary care. This was started in 2016 to support governments in strengthening the prevention and control of cardiovascular diseases (CVDs). Such initiations will boost the market in the coming years.
Thus, owing to the above-mentioned factors the market is expected to show growth over the forecast period. However, poor reimbursement policies, stringent regulatory policies, and the high cost of instruments and procedures are some of the major factors restraining market growth.
Key Market Trends
Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period
An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart's health.
Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Due to rising cases of cardiovascular diseases (CVD), wherein long-term ECG monitoring is necessary and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further fuels the market growth.
Furthermore, as per INE Chile, in 2017, circulatory disorders related to deaths were top among all deaths resulted in approximately 28,591 deaths in Chile. Therefore, the growing demand for minimally invasive surgeries and technological advancements is expected to drive the market in the near future.
Competitive Landscape
The Chile cardiovascular devices market is consolidated competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Boston Scientific Corporation, Medtronic PLC, Siemens Healthineers AG, Phillips Healthcare, Nihon Kohden Corporation, Welch Allyn, Inc, and GE Healthcare.
Reasons to Purchase this report:
This product will be delivered within 2 business days.
Cardiovascular disease is a major health problem in Chile. In Chile, the HEARTS program, a tool that provides a strategic approach to improving cardiovascular health through primary care. This was started in 2016 to support governments in strengthening the prevention and control of cardiovascular diseases (CVDs). Such initiations will boost the market in the coming years.
Thus, owing to the above-mentioned factors the market is expected to show growth over the forecast period. However, poor reimbursement policies, stringent regulatory policies, and the high cost of instruments and procedures are some of the major factors restraining market growth.
Key Market Trends
Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period
An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart's health.
Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Due to rising cases of cardiovascular diseases (CVD), wherein long-term ECG monitoring is necessary and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further fuels the market growth.
Furthermore, as per INE Chile, in 2017, circulatory disorders related to deaths were top among all deaths resulted in approximately 28,591 deaths in Chile. Therefore, the growing demand for minimally invasive surgeries and technological advancements is expected to drive the market in the near future.
Competitive Landscape
The Chile cardiovascular devices market is consolidated competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Boston Scientific Corporation, Medtronic PLC, Siemens Healthineers AG, Phillips Healthcare, Nihon Kohden Corporation, Welch Allyn, Inc, and GE Healthcare.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corporation
- Medtronic PLC
- Siemens Healthineers AG
- Phillips Healthcare
- Nihon Kohden Corporation
- Welch Allyn, Inc
- Abbott Laboratories
- GE Healthcare
Methodology
LOADING...
